1	Aglycon	_	NN	_	_	8	VMOD	_	_
2	of	_	IN	_	_	1	NMOD	_	_
3	rhizochalin	_	NN	_	_	2	PMOD	_	_
4	from	_	IN	_	_	1	NMOD	_	_
5	the	_	DT	_	_	7	NMOD	_	_
6	Rhizochalina	_	NN	_	_	7	NMOD	_	_
7	incrustata	_	NN	_	_	4	PMOD	_	_
8	induces	_	VBZ	_	_	0	ROOT	_	_
9	apoptosis	_	NN	_	_	8	VMOD	_	_
10	via	_	IN	_	_	8	VMOD	_	_
11	activation	_	NN	_	_	10	PMOD	_	_
12	of	_	IN	_	_	11	NMOD	_	_
13	AMP-activated	_	JJ	_	_	15	NMOD	_	_
14	protein	_	NN	_	_	15	NMOD	_	_
15	kinase	_	NN	_	_	12	PMOD	_	_
16	in	_	IN	_	_	15	NMOD	_	_
17	HT-29	_	NN	_	_	20	NMOD	_	_
18	colon	_	NN	_	_	20	NMOD	_	_
19	cancer	_	NN	_	_	20	NMOD	_	_
20	cells	_	NNS	_	_	16	PMOD	_	_
21	.	_	.	_	_	8	P	_	_
		
1	Rhizochalin	_	NN	_	_	2	VMOD	_	_
2	is	_	VBZ	_	_	0	ROOT	_	_
3	a	_	DT	_	_	6	NMOD	_	_
4	two-headed	_	JJ	_	_	6	NMOD	_	_
5	sphingolipid-like	_	JJ	_	_	6	NMOD	_	_
6	compound	_	NN	_	_	2	VMOD	_	_
7	isolated	_	VBN	_	_	6	APPO	_	_
8	from	_	IN	_	_	7	VMOD	_	_
9	the	_	DT	_	_	12	NMOD	_	_
10	sponge	_	NN	_	_	12	NMOD	_	_
11	Rhizochalina	_	NN	_	_	12	NMOD	_	_
12	incrustata	_	NN	_	_	8	PMOD	_	_
13	.	_	.	_	_	2	P	_	_
		
1	It	_	PRP	_	_	2	VMOD	_	_
2	has	_	VBZ	_	_	0	ROOT	_	_
3	been	_	VBN	_	_	2	VC	_	_
4	reported	_	VBN	_	_	3	VC	_	_
5	that	_	IN	_	_	4	VMOD	_	_
6	rhizocalin	_	NN	_	_	10	VMOD	_	_
7	and	_	CC	_	_	6	COORD	_	_
8	its	_	PRP$	_	_	9	NMOD	_	_
9	derivates	_	NNS	_	_	7	CONJ	_	_
10	have	_	VBP	_	_	5	SUB	_	_
11	a	_	DT	_	_	15	NMOD	_	_
12	chemopreventive	_	JJ	_	_	15	NMOD	_	_
13	and	_	CC	_	_	12	COORD	_	_
14	chemotherapeutic	_	JJ	_	_	13	CONJ	_	_
15	effect	_	NN	_	_	10	VMOD	_	_
16	.	_	.	_	_	2	P	_	_
		
1	However	_	RB	_	_	9	VMOD	_	_
2	,	_	,	_	_	9	P	_	_
3	the	_	DT	_	_	5	NMOD	_	_
4	molecular	_	JJ	_	_	5	NMOD	_	_
5	mechanism	_	NN	_	_	9	VMOD	_	_
6	of	_	IN	_	_	5	NMOD	_	_
7	these	_	DT	_	_	8	NMOD	_	_
8	effects	_	NNS	_	_	6	PMOD	_	_
9	is	_	VBZ	_	_	0	ROOT	_	_
10	not	_	RB	_	_	9	VMOD	_	_
11	understood	_	VBN	_	_	9	VC	_	_
12	.	_	.	_	_	9	P	_	_
		
1	Here	_	RB	_	_	4	VMOD	_	_
2	,	_	,	_	_	4	P	_	_
3	we	_	PRP	_	_	4	VMOD	_	_
4	demonstrate	_	VBP	_	_	0	ROOT	_	_
5	that	_	IN	_	_	4	VMOD	_	_
6	aglycon	_	NN	_	_	16	VMOD	_	_
7	of	_	IN	_	_	6	NMOD	_	_
8	rhizochalin	_	NN	_	_	7	PMOD	_	_
9	(	_	(	_	_	10	P	_	_
10	AglRhz	_	NN	_	_	8	PRN	_	_
11	)	_	)	_	_	10	P	_	_
12	from	_	IN	_	_	6	NMOD	_	_
13	the	_	DT	_	_	15	NMOD	_	_
14	Rhizochalina	_	NN	_	_	15	NMOD	_	_
15	incrustata	_	NN	_	_	12	PMOD	_	_
16	induces	_	VBZ	_	_	5	SUB	_	_
17	AMP-activated	_	JJ	_	_	19	NMOD	_	_
18	protein	_	NN	_	_	19	NMOD	_	_
19	kinase	_	NN	_	_	23	NMOD	_	_
20	(	_	(	_	_	21	P	_	_
21	AMPK	_	NN	_	_	19	PRN	_	_
22	)	_	)	_	_	21	P	_	_
23	phosphorylation	_	NN	_	_	16	VMOD	_	_
24	,	_	,	_	_	16	P	_	_
25	and	_	CC	_	_	16	COORD	_	_
26	thereby	_	RB	_	_	27	VMOD	_	_
27	inhibits	_	VBZ	_	_	25	CONJ	_	_
28	mammalian	_	JJ	_	_	29	NMOD	_	_
29	target	_	NN	_	_	27	VMOD	_	_
30	of	_	IN	_	_	29	NMOD	_	_
31	rapamycin	_	NN	_	_	38	NMOD	_	_
32	(	_	(	_	_	38	P	_	_
33	mTOR	_	NN	_	_	38	NMOD	_	_
34	)	_	)	_	_	38	P	_	_
35	-p70S6	_	NN	_	_	38	NMOD	_	_
36	kinase-extracellular	_	JJ	_	_	38	NMOD	_	_
37	signal-regulated	_	JJ	_	_	38	NMOD	_	_
38	kinase	_	NN	_	_	42	NMOD	_	_
39	(	_	(	_	_	40	P	_	_
40	ERK	_	NN	_	_	38	PRN	_	_
41	)	_	)	_	_	40	P	_	_
42	signaling	_	NN	_	_	30	PMOD	_	_
43	and	_	CC	_	_	42	COORD	_	_
44	activator	_	NN	_	_	45	NMOD	_	_
45	protein	_	NN	_	_	50	NMOD	_	_
46	1	_	CD	_	_	45	NMOD	_	_
47	(	_	(	_	_	48	P	_	_
48	AP-1	_	NN	_	_	45	PRN	_	_
49	)	_	)	_	_	48	P	_	_
50	activity	_	NN	_	_	43	CONJ	_	_
51	via	_	IN	_	_	27	VMOD	_	_
52	phosphorylation	_	NN	_	_	51	PMOD	_	_
53	of	_	IN	_	_	52	NMOD	_	_
54	Raptor	_	NN	_	_	53	PMOD	_	_
55	in	_	IN	_	_	52	NMOD	_	_
56	HT-29	_	NN	_	_	57	NMOD	_	_
57	cells	_	NNS	_	_	55	PMOD	_	_
58	.	_	.	_	_	4	P	_	_
		
1	In	_	IN	_	_	23	VMOD	_	_
2	addition	_	NN	_	_	1	PMOD	_	_
3	,	_	,	_	_	23	P	_	_
4	AglRhz	_	JJ	_	_	6	NMOD	_	_
5	induced	_	JJ	_	_	6	NMOD	_	_
6	activation	_	NN	_	_	23	VMOD	_	_
7	of	_	IN	_	_	6	NMOD	_	_
8	caspase-3	_	NN	_	_	7	PMOD	_	_
9	and	_	CC	_	_	8	COORD	_	_
10	poly(ADP-ribose)	_	JJ	_	_	11	NMOD	_	_
11	polymerase	_	NN	_	_	9	CONJ	_	_
12	(	_	(	_	_	13	P	_	_
13	PARP	_	NN	_	_	11	PRN	_	_
14	)	_	)	_	_	13	P	_	_
15	,	_	,	_	_	6	P	_	_
16	and	_	CC	_	_	6	COORD	_	_
17	DNA	_	NN	_	_	18	NMOD	_	_
18	fragmentation	_	NN	_	_	16	CONJ	_	_
19	in	_	IN	_	_	18	NMOD	_	_
20	HT-29	_	NN	_	_	21	NMOD	_	_
21	cells	_	NNS	_	_	19	PMOD	_	_
22	,	_	,	_	_	6	P	_	_
23	leads	_	VBZ	_	_	0	ROOT	_	_
24	to	_	TO	_	_	23	VMOD	_	_
25	induction	_	NN	_	_	24	PMOD	_	_
26	of	_	IN	_	_	25	NMOD	_	_
27	apoptosis	_	NN	_	_	26	PMOD	_	_
28	as	_	RB	_	_	25	COORD	_	_
29	well	_	RB	_	_	28	DEP	_	_
30	as	_	IN	_	_	28	DEP	_	_
31	suppression	_	NN	_	_	28	CONJ	_	_
32	of	_	IN	_	_	31	NMOD	_	_
33	tumorigenicity	_	NN	_	_	32	PMOD	_	_
34	of	_	IN	_	_	33	NMOD	_	_
35	HT-29	_	NN	_	_	36	NMOD	_	_
36	cells	_	NNS	_	_	34	PMOD	_	_
37	.	_	.	_	_	23	P	_	_
		
1	Notably	_	RB	_	_	4	VMOD	_	_
2	,	_	,	_	_	4	P	_	_
3	AglRhz	_	NN	_	_	4	VMOD	_	_
4	inhibits	_	VBZ	_	_	0	ROOT	_	_
5	insulin-like	_	JJ	_	_	7	NMOD	_	_
6	growth	_	NN	_	_	7	NMOD	_	_
7	factor	_	NN	_	_	9	AMOD	_	_
8	(	_	(	_	_	9	P	_	_
9	IGF	_	NN	_	_	13	NMOD	_	_
10	)	_	)	_	_	9	P	_	_
11	-1-induced	_	JJ	_	_	9	AMOD	_	_
12	AP-1	_	NN	_	_	13	NMOD	_	_
13	activity	_	NN	_	_	4	VMOD	_	_
14	and	_	CC	_	_	13	COORD	_	_
15	cell	_	NN	_	_	16	NMOD	_	_
16	transformation	_	NN	_	_	14	CONJ	_	_
17	in	_	IN	_	_	13	NMOD	_	_
18	JB6	_	NN	_	_	20	NMOD	_	_
19	Cl41	_	NN	_	_	20	NMOD	_	_
20	cells	_	NNS	_	_	17	PMOD	_	_
21	.	_	.	_	_	4	P	_	_
		
1	Overall	_	RB	_	_	5	VMOD	_	_
2	,	_	,	_	_	5	P	_	_
3	our	_	PRP$	_	_	4	NMOD	_	_
4	findings	_	NNS	_	_	5	VMOD	_	_
5	identify	_	VBP	_	_	0	ROOT	_	_
6	AMPK	_	NN	_	_	5	VMOD	_	_
7	as	_	IN	_	_	5	VMOD	_	_
8	an	_	DT	_	_	11	NMOD	_	_
9	important	_	JJ	_	_	11	NMOD	_	_
10	target	_	NN	_	_	11	NMOD	_	_
11	protein	_	NN	_	_	7	PMOD	_	_
12	for	_	IN	_	_	11	NMOD	_	_
13	mediating	_	VBG	_	_	12	PMOD	_	_
14	the	_	DT	_	_	16	NMOD	_	_
15	anti-tumor	_	JJ	_	_	16	NMOD	_	_
16	properties	_	NNS	_	_	13	VMOD	_	_
17	of	_	IN	_	_	16	NMOD	_	_
18	AglRhz	_	NN	_	_	17	PMOD	_	_
19	in	_	IN	_	_	16	NMOD	_	_
20	HT-29	_	NN	_	_	23	NMOD	_	_
21	colon	_	NN	_	_	23	NMOD	_	_
22	cancer	_	NN	_	_	23	NMOD	_	_
23	cells	_	NNS	_	_	19	PMOD	_	_
24	and	_	CC	_	_	5	COORD	_	_
25	have	_	VBP	_	_	24	CONJ	_	_
26	important	_	JJ	_	_	27	NMOD	_	_
27	implication	_	NN	_	_	25	VMOD	_	_
28	for	_	IN	_	_	27	NMOD	_	_
29	sponges	_	NNS	_	_	28	PMOD	_	_
30	,	_	,	_	_	29	P	_	_
31	the	_	DT	_	_	35	NMOD	_	_
32	most	_	RBS	_	_	33	AMOD	_	_
33	important	_	JJ	_	_	35	NMOD	_	_
34	marine	_	NN	_	_	35	NMOD	_	_
35	source	_	NN	_	_	29	APPO	_	_
36	,	_	,	_	_	29	P	_	_
37	in	_	IN	_	_	27	NMOD	_	_
38	colon	_	NN	_	_	39	NMOD	_	_
39	cancer	_	NN	_	_	37	PMOD	_	_
40	.	_	.	_	_	5	P	_	_
		
